Dr. Joshua Arthur Mcdonald, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 390 N Main St, Bountiful, UT 84010 Phone: 801-397-6400 |
Jordan Scott Carver, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1551 Renaissance Towne Dr, #104, Bountiful, UT 84010 Phone: 801-295-6979 Fax: 801-295-6989 |
Mrs. Janet Louise Norman, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 47 E 500 S, Bountiful, UT 84010 Phone: 801-295-3463 |
Lauren Goff Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 555 S 200 W, Bountiful, UT 84010 Phone: 801-397-7833 |
Michael Duane Alakai Montalbo Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 573 W 100 N, Bountiful, UT 84010 Phone: 801-299-3968 Fax: 801-299-3965 |
Ms. Cecelia F. Jones, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 535 S 200 W, Bountiful, UT 84010 Phone: 801-298-9030 |
Dr. Paul Hinckley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 535 S Main St, Bountiful, UT 84010 Phone: 801-298-3100 |
George Deloy Loertscher, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1631 S 75 E, Bountiful, UT 84010 Phone: 801-499-2402 |
Mr. Marc Stafford Harward, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 555 S 200 W, Bountiful, UT 84010 Phone: 801-397-7833 Fax: 801-397-7827 |
Thomas M Pruess, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 390 N Main St, Bountiful, UT 84010 Phone: 801-294-1005 Fax: 801-294-1052 |
Tyler Wiseman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 S 500 W, Bountiful, UT 84010 Phone: 801-294-9107 |
Dr. Damien Powers, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 535 S Main St, Bountiful, UT 84010 Phone: 801-298-3100 Fax: 801-298-9083 |
Michael Charles Rognon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 390 N Main St, Bountiful, UT 84010 Phone: 801-397-6360 Fax: 801-397-6369 |
Afton Melissa Allen, PHARM D Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 555 S 200 W, Bountiful, UT 84010 Phone: 801-397-7833 Fax: 801-397-7827 |
Greg Mendiola, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 630 Medical Dr, Bountiful, UT 84010 Phone: 801-299-2118 |
Kathryn Ann Goodfellow, R. PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 Medical Dr, Suite 100, Bountiful, UT 84010 Phone: 801-295-3439 Fax: 801-299-1696 |
Kristina Everett, B.S. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2280 Orchard Dr, Bountiful, UT 84010 Phone: 801-296-2222 |
John L Wendt Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 535 S Main St, Bountiful, UT 84010 Phone: 801-414-4201 |
Mrs. Andrea Myers, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 W 500 S, Bountiful, UT 84010 Phone: 801-294-9107 |
Marilou Miner Krstyen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 573 W 100 N, Bountiful, UT 84010 Phone: 801-299-3968 Fax: 801-299-3965 |
News Archive
In a new study documenting the microbial landscape of New Orleans and Lake Pontchartrain in the wake of Hurricanes Katrina and Rita, scientists report that sediments in interior portions of the city appear to be contaminated with fecal microbes, a chronic condition they say persisted in the area before the hurricanes, and that the resulting water quality in the city and in nearshore waters of the lake continues to be impacted by discharges from this contamination.
EarlySense, the market leader in contact-free continuous monitoring solutions, announced today new research that confirms high accuracy of its home consumer sensor when compared to polysomnography (PSG), the testing process used in clinics around the world to detect sleeping disorders.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
When tumour cells no longer degrade themselves, cancer may develop. Using black skin cancer as an example, Bern Researchers have now shown that a protein plays an important role in the process of degradation of tumour cells. By reactivating this degradation therapeutically, you can virtually force tumours to digest themselves.
› Verified 7 days ago